Company profilePharmaceutical#475 of 1,318 in Pakistan✓ No DRAP alerts

himark laboratories (pvt.) Ltd

Pharmaceutical company · 30 brands · 29 molecules

30 registered products 27 pharmaceutical brands 29 distinct molecules 0 DRAP alerts

Company overview

30
registered products
27
pharmaceutical brands
29
distinct molecules
0
therapeutic classes
0
DRAP alerts

himark laboratories (pvt.) Ltd is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 30 product registrations across 29 distinct molecules. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by himark

26 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

26
ceilings with an approval date
24
not revised in 2+ years
2024
oldest approval year
202424
20262
Longest without revision

Top molecules by brand count

Azithromycin4 brands
Omeprazole3 brands
Paracetamol3 brands
Fexofenadine3 brands
Levofloxacin2 brands
Loratadine2 brands
Clarithromycin ...... 125 Mg1 brand

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official38 products · Rs 40.07 – Rs 810.39
Median across source: Rs 271.91

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

MACTER INTERNATIONAL (PVT) LTD. holds 168 molecules not in this portfolio
000 I.U10Ug Polysaccharides Covalently Bound To 20Ug To 32Ug Of Tetanus ToxoidAlbendazoleAlbuterolAlfacalcidolAluminium Hydroxide
MEDIATE PHARMACEUTICALS (PVT) LTD holds 103 molecules not in this portfolio
AcyclovirAlendronateAmlodipineAmoxicillinAmpicillinAmpicillin Base
SEMOS PHARMACEUTICALS (PVT) LTD. holds 48 molecules not in this portfolio
AmodiaquineAmodiaquine 150MgArtemetherArtesunateAscorbic AcidBisacodyl

Get the full profile for himark

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.